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Chemical probing of thiotetronate bio-assembly†
Judith Havemann,a Marie E. Yurkovich,b Robert Jenkins,a Sophia Harringer,a
Weixin Tao,c Shishi Wen,c Yuhui Sun,c Peter F. Leadlayb and Manuela Tosin*a
Chemical ‘chain termination’ probes were utilised for the investiga-
tion of thiotetronate antibiotic biosynthesis in the filamentous
bacteria Lentzea sp. and Streptomyces thiolactonus NRRL 15439.
The use of these tools led to the capture of biosynthetic inter-
mediates involved in the thiotetronate polyketide backbone assembly,
providing first insights into substrate specificity and in vivo intermedi-
ate processing by unusual iterative synthases.
Polyketide natural products constitute a prominent class of
secondary metabolites that interact with a wide range of
intracellular targets associated with diseases.1 The presence
of heterocyclic moieties in polyketides, such as pyran and furan
rings in ionophore antibiotics, is common and often decisive for
the physical properties and biological activity of the compound.2
Although sulphur-ring based structures are relatively common in
peptides of both ribosomal and nonribosomal origin,3 polyketides
bearing sulphur-containing rings are rare. They include potent
antitumor agents such as leinamycin4 and the family of thiote-
tronate antibiotics (Fig. 1).5–10 Thiotetronates are characterised by
thiolactone moieties functionalised with different substituents at
positions 3, 5 and 7, a tetronate moiety spanning carbons 2–4 and
a stereogenic centre at carbon 5. The best-known thiotetronate is
thiolactomycin (1, TLM): originally isolated from a soil Nocardia
strain (ATCC 31319,7 recently reclassified as Lentzea sp.), 1 is a
reversible inhibitor of the b-ketoacyl-acyl carrier protein synthase
(KAS) enzymes of the bacterial type II (dissociated) fatty acid
synthase.11 TLM constitutes a promising lead structure for the
development of novel anti-tuberculosis, anti-malarial and anti-
trypanosomal agents.12–14 The closely structurally related Tu¨ 3010
(2) has been reported to be the most potent antibacterial tetronate
to date, capable of targeting FabH/FabF in Staphylococcus aureus at
lower doses in comparison to TLM and other known FabH/FabF
inhibitors.15 Only very recently these medicinally promising
molecules were unequivocally established to be of polyketide
origin.5–6,16 Comparative genomics-based approaches to orphan
cluster identification led to the uncovering of putative polyketide
synthase (PKS)-nonribosomal peptide synthetase (NRPS) enzymes
(A–C, Fig. 1B) responsible for thiotetronate production in both soil
and marine bacteria, in association with tailoring enzymes (e.g.
P450 oxidases, D), cysteine desulfurases ( J) and (thiouridylase-
like) sulfur transferases (S) proposed to provide the sulfur atom
for thiotetronate ring formation.5,6 Indeed, genes A, B, D1, D2,
J and S are essential for thiotetronate formation, as proved by
in vivo knock-out and complementation studies.5 Genes A and B
encode for an acetyl-loading PKS module and a hybrid PKS-NRPS,
respectively. For the thiolactomycin biosynthetic gene cluster tlm,
the B protein comprises ketosynthase (KS), acyltransferase (AT),
Fig. 1 (A) Structure of thiotetronate polyketides thiolactomycin (1) and Tu¨
3010 (2) and (B) overview of their recently elucidated gene clusters from
Lentzea sp. and S. thiolactonus NRRL 15439, respectively.5,6 Legend: J =
tRNA-specific thiouridylase; K = N-acetylmuramoyl-L-alanine amidase;
S = NifS-like cysteine desulfurase; E = asparagine synthase; G = ferredoxin;
D1 and D2 = cytochrome P450s; F3 = 3-oxoacyl-ACP-synthase III (FabH);
T = thioesterase; H = crotonyl-CoA reductase; I = 3-hydroxybutyryl-CoA
dehydrogenase; R = LuxR family transcriptional regulator; F, F1 and F2 =
3-oxoacyl-ACP-synthases (FabB/F); A = PKS; B = PKS/NRPS; C = NRPS.
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dehydratase (DH), ketoreductase (KR), acyl carrier protein (ACP),
cyclisation (Cy), adenylation (A), peptidyl carrier protein (PCP) and
thioesterase (TE) domains (Fig. 3). A number of biosynthetic
hypotheses have been so far proposed regarding the origins of
TLM and other thiotetronates on the basis of precursor feeding
studies16 and gene/protein bioinformatics.5,6 However, the actual
molecular mechanisms of product assembly remain undetermined
and are the object of intense scrutiny with a view to thiotetronate
structural diversification via enzyme engineering.
Polyketide biosynthesis proceeds via decarboxylative Claisen
condensation of malonate units anchored to acyl carrier pro-
teins (ACPs) with acyl moieties bound to ketosynthase (KS)
domains (Fig. 3, path A): the resulting polyketide chain is
subjected to variable ketoreduction, dehydration and enoyl
reduction after chain extension, before being released from
PKSs (e.g. via thioester hydrolysis) and/or post-PKS tailoring
(e.g. viamethyltransferases, glycosyltransferases,. . .).17,18 A detailed
elucidation of the polyketide assembly is crucial for knowledge-
based enzyme and cell engineering aiming at novel polyketide
production.19–21 Advances in molecular biology, synthetic
chemistry and analytical techniques have greatly aided the
probing of PKS pathways in vitro and in vivo.5,6,22–25 Nonetheless,
several challenges remain concerning the elucidation of timing
and mechanisms related to the polyketide assembly, mostly
related to the inaccessibility of biosynthetic intermediates
covalently linked to PKSs throughout the product assembly.
We have developed a general strategy for probing polyketide
biocatalysis based on the use of synthetic ‘chain termination’
probes: these are nonhydrolysable small-molecule mimics of
malonate extender units recruited in polyketide formation that
competitively interfere in the decarboxylative Claisen conden-
sation to capture and oﬀ-load prematurely truncated bio-
synthetic intermediates (Fig. 3, path B).26–32 These chemical
tools have proved successful for the identification and char-
acterisation of intermediate species from modular26–29,32 and
iterative30,31 PKSs, in vitro and in vivo, allowing the gathering of
otherwise inaccessible information on the timing and the
mechanism of single catalytic events,28,30 and also unveiling
novel chemoenzymatic opportunities for the generation of
unnatural polyketide derivatives.29 In order to shed light on
the nature of the biosynthetic intermediates involved in the
thiotetronate assembly and their in vivo processing, we have
utilised a range of chain termination probes available in our
labs. We initially employed the N-(d3) acetyl methyl ester probes
3a–b, which hydrolyse in vivo to the corresponding ‘active’
carboxylate probes 7a–b (Fig. 2), in microbial fermentations
of the wild type thiolactomycin producing Lentzea sp. at variable
probe concentrations. In organic extracts of cultures we observed
diminished production of thiolactomycin with increasing con-
centrations of 3a–b, strongly suggesting that the probes were
interfering in the thiotetronate assembly. However, only a hand-
ful of putative captured intermediates were detected from these
substrates (Table S2, ESI†). We therefore turned to second-
generation probes featuring N-decanoyl chains, which have
recently proved to be more efficient tools in capturing polyketide
intermediates in vivo due to their enhanced bioavailability and
ease of intermediate isolation.32 In addition to substrates 4–5
previously reported,29–32 we also synthesised and utilised the
pseudo-methylmalonyl ester 6 (Scheme S1, ESI†), in order to
probe the extender unit substrate specificity of the putative
iterative PKSs. In parallel to wild-type strains, mutant strains
carrying specific deletions in both Lentzea sp. (DtlmA,5 DtlmD15
and Dcy) and S. thiolactonus NRRL 15439 (DstuB and DJDKDS),5
as well as Streptomyces avermitilis heterologously expressing the
Tu¨ 3010 cluster,5 were utilised in control experiments.
An overview of the outcome of feeding experiments of
Lentzea sp. and S. thiolactonus strains with compounds 7–10
is given in Fig. 3 and detailed in Tables S2–S5 (ESI†). Although
malonate and methylmalonate-mimic probes 8 and 10 prefer-
entially intercepted early stage condensation intermediates, the
use of the fluoromalonate-based probe 9 in wild-type Lentzea sp.
fermentations captured diketides and triketides presenting
various degrees of reduction, as well as putative tetraketides
(Table S2, ESI†). These species, directly mirroring the nature of
ACP-bound species,5 were characterised by high resolution
mass spectrometry tandem experiments, with diagnostic peaks
corresponding to the loss of the N-decanoyl moiety and loss of
ammonia, and/or cyclic imine formation29–32 (Fig. 3). Although
diketide species may be potentially captured from the fatty acid
biosynthetic pathway (Table S3, ESI†), the observed triketides
and tetraketides were associated exclusively with TLM forma-
tion in vivo. In addition to purely polyketide species, a putative
S- and O- containing tetraketide species was also captured from
Lentzea sp. via 9 (Fig. 3C). A parallel investigation of S. thiolactonus
wild-type, deletion mutant strains and S. avermitilis heterologously
expressing the Tu¨ 3010 cluster5 with methyl ester substrates 4–5
led to the capture of similar putative intermediates, albeit with
lower efficiency (Tables S4 and S5, ESI†).
These results taken together constitute the first direct
evidence of polyketide chain building and processing involved
in thiotetronate bio-assembly. By utilising a variety of chemical
probes as pseudo-malonate substrates, preliminary informa-
tion on substrate specificity and the kinetics of polyketide
assembly has been obtained. The pseudo-fluoromalonate 9,
generated from in vivo hydrolysis of the corresponding methyl
ester 5, proved to be the most eﬃcient tool in capturing almost
every intermediate involved in the polyketide TLM assembly.
Compared to the malonate and methylmalonate inspired-
substrates 4 and 6, we observed enhanced in vivo ester hydrolysis
followed by decarboxylation for 5 (Fig. S7, S10 and S20, ESI†):
this is possibly due to the electron-withdrawing eﬀect of fluorine
at the a-ester carbonyl position, or to the increased probe
bioavailability, or to a likely combination of both. On the other
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hand, 9 did not prove equally eﬃcient in sampling the poly-
ketide chain assembly for Tu¨ 3010, suggesting a much stricter
substrate specificity for StuB. By analysing the relative amounts
of all the characterised species from Lentzea sp., it appears that,
in general, early stage substrate processing is relatively slow, as
previously observed for other partially reducing iterative type I
synthases (iPKSs),30,31 and that the presence of TlmD1, the TlmB Cy
domain and J, K, S proteins is essential for polyketide chain growth
and processing beyond the triketide stage. Most type I iPKSs utilise
malonate extender units, and methyl groups are introduced into
their polyketide products by integral SAM-dependent methyl-
transferases.33,34 In this respect, TlmB and StuB display unusual
substrate specificity in utilisingmethylmalonate and ethylmalonate
extender units, dictated by their respective AT domains. We have
shown here that these unusual iPKSs can also process pseudo-
malonate, methylmalonate and fluoromalonate substrates at
diﬀerent stages and to various extents. These findings have been
corroborated by parallel in vitro investigations with recombinant
TlmB in our laboratories.35 We have recently proposed a
mechanism for sulphur insertion following the formation of
the PKS-bound tetraketide, involving the nonribosomal peptide
synthase (NRPS) functionalities encoded in the C-terminal part
of TlmB: tetraketide epoxidation (catalysed by TlmD1/StuD1)
may precede the formation of a tetraketide–thiirane intermedi-
ate from PCP-bound cysteine desulfuration (Tlm/Stu J and S
catalysed), followed by heterocyclisation and product release.5
It is tempting to speculate that the putative S- and O- contain-
ing tetraketide species characterised from Lentzea sp. and
S. thiolactonus wild-type strains may be related to this pathway.
Further work will be required to establish the true nature of
S-containing intermediates leading to thiotetronate formation.
Nevertheless, the deconvolution of the steps of chain assembly
reported here has set the stage for the investigation of these
post-PKS events.
In summary, we have utilised chemical probes to gather the
first information on the intermediates in polyketide assembly for
thiotetronate formation in vivo. This represents an important
step towards the full elucidation of thiotetronate assembly and
the development of synthetic biology-based routes for novel
thiotetronate production.
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Science Foundation of China (project grant 31300061 to W. T.);
Dr Cleidiane Zampronio (School of Life Sciences, Warwick) for
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Fusion instrument; and Dr Lijiang Song for preliminary MS data
acquired on a MaXis Bruker Impact instrument.
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